Manufacturing Chemist – February 26, 2016
Generic drugs costs have climbed dramatically in recent years, hitting US patients and producers. Edward S. Price, PCI Synthesis, argues it’s time the increasing costs were addressed.
A brief excerpt is available on ManufacturingChemist.com. The full article is available ONLY to subscribers of Manufacturing Chemist. Subscribe now to Manufacturing Chemist.